$2.41T
Total marketcap
$81.32B
Total volume
BTC 50.72%     ETH 16.98%
Dominance

Awakn Life Sciences Corp. 954.F Stock

0.06 EUR {{ price }} -9.160301% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
3.13M EUR
LOW - HIGH [24H]
0.07 - 0.07 EUR
VOLUME [24H]
54.37K EUR
{{ volume }}
P/E Ratio
0
Earnings per share
-0.09 EUR

Awakn Life Sciences Corp. Price Chart

Awakn Life Sciences Corp. 954.F Financial and Trading Overview

Awakn Life Sciences Corp. stock price 0.06 EUR
Previous Close 0.17 EUR
Open 0.13 EUR
Bid 0 EUR x N/A
Ask 0 EUR x N/A
Day's Range 0.14 - 0.14 EUR
52 Week Range 0.12 - 0.69 EUR
Volume 10.11K EUR
Avg. Volume 179 EUR
Market Cap 5.15M EUR
Beta (5Y Monthly) N/A
PE Ratio (TTM) N/A
EPS (TTM) -0.09 EUR
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

954.F Valuation Measures

Enterprise Value 5.9M EUR
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 2.9390075
Price/Book (mrq) N/A
Enterprise Value/Revenue 3.364
Enterprise Value/EBITDA -0.731

Trading Information

Awakn Life Sciences Corp. Stock Price History

Beta (5Y Monthly) N/A
52-Week Change -65.11%
S&P500 52-Week Change 20.43%
52 Week High 0.69 EUR
52 Week Low 0.12 EUR
50-Day Moving Average 0.18 EUR
200-Day Moving Average 0.25 EUR

954.F Share Statistics

Avg. Volume (3 month) 179 EUR
Avg. Daily Volume (10-Days) 500 EUR
Shares Outstanding 35.04M
Float 19.29M
Short Ratio N/A
% Held by Insiders 1.91%
% Held by Institutions 8.34%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends January 31, 2023
Most Recent Quarter (mrq) April 30, 2023
Next Fiscal Year End January 31, 2024

Profitability

Profit Margin 0%
Operating Margin (ttm) -484.65%
Gross Margin -94.13%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -87.31%
Return on Equity (ttm) -597.57%

Income Statement

Revenue (ttm) 1.75M EUR
Revenue Per Share (ttm) 0.07 EUR
Quarterly Revenue Growth (yoy) 101.79%
Gross Profit (ttm) N/A
EBITDA -8067242 EUR
Net Income Avi to Common (ttm) -8014349 EUR
Diluted EPS (ttm) -0.23
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 389.7K EUR
Total Cash Per Share (mrq) 0.02 EUR
Total Debt (mrq) 2.48M EUR
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.261
Book Value Per Share (mrq) -0.029

Cash Flow Statement

Operating Cash Flow (ttm) -6130310 EUR
Levered Free Cash Flow (ttm) -3683961 EUR

Profile of Awakn Life Sciences Corp.

Country Germany
State ON
City Toronto
Address 301-217 Queen Street West
ZIP M5V 0R2
Phone N/A
Website https://awaknlifesciences.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 44

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD. Awakn Life Sciences Corp. is headquartered in Toronto, Canada.

Q&A For Awakn Life Sciences Corp. Stock

What is a current 954.F stock price?

Awakn Life Sciences Corp. 954.F stock price today per share is 0.06 EUR.

How to purchase Awakn Life Sciences Corp. stock?

You can buy 954.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Awakn Life Sciences Corp.?

The stock symbol or ticker of Awakn Life Sciences Corp. is 954.F.

Which industry does the Awakn Life Sciences Corp. company belong to?

The Awakn Life Sciences Corp. industry is Biotechnology.

How many shares does Awakn Life Sciences Corp. have in circulation?

The max supply of Awakn Life Sciences Corp. shares is 52.59M.

What is Awakn Life Sciences Corp. Price to Earnings Ratio (PE Ratio)?

Awakn Life Sciences Corp. PE Ratio is now.

What was Awakn Life Sciences Corp. earnings per share over the trailing 12 months (TTM)?

Awakn Life Sciences Corp. EPS is -0.09 EUR over the trailing 12 months.

Which sector does the Awakn Life Sciences Corp. company belong to?

The Awakn Life Sciences Corp. sector is Healthcare.